Huntington’s disease
Using an in vitro kinome screen, the lab of Hilal Lashuel at EPFL identified a
Neurons affected by the huntingtin protein. Credit: Dr. Steven Finkbeiner, Gladstone Institute of Neurological Disease,
Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells
The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its
A new way to regulate protein levels and functions could be the answer to treating
Scientists have described a way to convert human skin cells directly into a specific type
Mechanism uncovered could also help preserve neuron function in Alzheimer’s disease, traumatic brain injury and
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington’s disease, depression